
Company Introduction
Founded in 2018, Belief BioMed is aiming to become a globally leading gene therapy company by being committed to providing innovative therapies with improved efficacy for monogenic disorder diseases, age-related degenerative diseases, and certain malignant diseases through its AAV vector technology from early discovery to commercialization. The R&D and production strengths of Belief BioMed have been recognized by top investment institutions and enterprises. Belief BioMed has offices, research centers and manufacturing facilities in Shanghai, Hong Kong, Beijing and Suzhou China and North Carolina US.
Mission And Vision

Our Mission
Make gene therapy drugs available, affordable and healable.

Our Vision
To become the pioneer leading China’s gene therapy industry, to bring China’s gene therapy drugs to the world.
Key Milestones
Management Team

Xiao Xiao
Co-Founder, Chairman and CSO, Ph.D.
Ph.D. in Molecular Biology, University of Pittsburgh
Co-founder of Bamboo / Askbio

Jane Zheng
Co-founder and CEO, Ph.D.
PhD from Institute of Neurology, Chinese Academy of Sciences
Co-founder of Genechem / Neuron Biotech

Hao Zheng
Operations, SVP
Tianjin university Pharmaceutical engineering, Bachelor
15 years of experience in pharmaceutical operation management

Hui Chen
Portfolio Regulatory, VP
Fudan University, Master
19 years of experience in pharmaceutical R&D

Xia Wu
Discovery, VP
Utah State University, Postdoc.
15 years of experience in AAV early discovery

Wei Jiang
Analytical Development, Senior Director
Shanghai Institute of Biochemistry and Cell Biology, CAS, Ph.D.
8 years of experience in AAV vector application

Zengmin Du
Process R&D, Senior Director
East China University of Science and Technology, Ph.D.
8 years of experience in AAV vector R&D

Yue Dun
Clinical, VP
Peking University, Master
15 years of experience in clinical development

Philip Sin
Head of Capital Markets and Corporate Development